Spring Bank Signs a Research Agreement with the University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds

Shots:

Spring Bank enters into a collaboration with the University of Texas Southwestern Medical Center for the evaluation of Spring Bank’s STimulator of INterferon Gene (STING) antagonist compounds in autoimmune disease models
Spring Bank will evaluate novel STING antagonist compounds in mouse models of autoimmune and inflammatory diseases to meet the unmet medical need for the diseases in which cGAS-STING pathway is dysregulated
Spring Bank’s STING antagonist compounds are designed to block aberrant STING-dependent signaling via a novel mechanism of action and being developed for autoimmune diseases including multiple interferonopathies

Click here to read full press release/ article | Ref: Spring Bank | Image: Market Beat